XFOR (X4 Pharmaceuticals) Institutional Ownership: 108.04% (As of Jun. 29, 2026)


XFOR X4 Pharmaceuticals Inc XFOR
29 GF Score
Price $4.15
! 6 Warning Signs
View Full Analysis

What is X4 Pharmaceuticals Institutional Ownership?

X4 Pharmaceuticals XFOR +3.11% 29 Institutional Ownership is 108.04% as of Jun. 29, 2026. GuruFocus rates XFOR with a GF Score™ of 29/100. The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, X4 Pharmaceuticals's institutional ownership is 108.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, X4 Pharmaceuticals's Insider Ownership is 9.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, X4 Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.79%.

X4 Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for X4 Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

X4 Pharmaceuticals Institutional Ownership Chart

X4 Pharmaceuticals Historical Data

The historical data trend for X4 Pharmaceuticals can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 2.31 2.59 13.93 16.06 23.09 23.78 23.66 23.54 23.12 23.16
XFOR
29GF Score
X4 Pharmaceuticals Inc XFOR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

X4 Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 108.04% mean?
X4 Pharmaceuticals (XFOR) has a Institutional Ownership of 108.04% as of Jun. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on X4 Pharmaceuticals and its competitors.
Is X4 Pharmaceuticals' Institutional Ownership too high?
X4 Pharmaceuticals' current Institutional Ownership is 108.04%. Overall, X4 Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does X4 Pharmaceuticals' Institutional Ownership compare to CMPX and LRMR?
X4 Pharmaceuticals' Institutional Ownership of 108.04% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on X4 Pharmaceuticals and its competitors. X4 Pharmaceuticals's current Institutional Ownership is 108.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X4 Pharmaceuticals stock overvalued right now?
X4 Pharmaceuticals (XFOR) has a current Institutional Ownership of 108.04%. The current Institutional Ownership is 108.04%. X4 Pharmaceuticals' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For X4 Pharmaceuticals (XFOR), the current Institutional Ownership is 108.04% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

X4 Pharmaceuticals Business Description

Address 61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
29GF Score

Get the complete analysis for XFOR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price